Farallon Capital Management LLC Capricor Therapeutics, Inc. Transaction History
Farallon Capital Management LLC
- $22.3 Billion
- Q2 2025
A detailed history of Farallon Capital Management LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 41,000 shares of CAPR stock, worth $329,639. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,000Holding current value
$329,639% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding CAPR
# of Institutions
139Shares Held
12.3MCall Options Held
4.98MPut Options Held
5.48M-
Vanguard Group Inc Valley Forge, PA2.31MShares$18.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$13.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$11.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$7.74 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$4.43 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $196M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...